RT Journal Article
SR Electronic
T1 Stimulation of Guanosine-5′-O-(3-[35S]thio)triphosphate Binding in Digitonin-Permeabilized C6 Rat Glioma Cells: Evidence for an Organized Association of μ-Opioid Receptors and G Protein
JF Journal of Pharmacology and Experimental Therapeutics
JO J Pharmacol Exp Ther
FD American Society for Pharmacology and Experimental Therapeutics
SP 116
OP 121
VO 298
IS 1
A1 Andrew Alt
A1 Iain J. McFadyen
A1 Charles D. Fan
A1 James H. Woods
A1 John R. Traynor
YR 2001
UL http://jpet.aspetjournals.org/content/298/1/116.abstract
AB The guanosine-5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding assay for the determination of relative opioid efficacy has been adapted to measure G protein activation in digitonin-permeabilized C6 rat glioma cells expressing a cloned μ-opioid receptor. The μ-agonist [d-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) caused a 3-fold increase in [35S]GTPγS binding over basal in a naloxone-sensitive manner. Relative μ-agonist efficacy was DAMGO > fentanyl ≥ morphine > buprenorphine. Nalbuphine showed no efficacy. G protein activation by receptors has been predicted to occur by random encounter. In this model a reduction in the number of receptors will decrease the rate of G protein activation but not the maximum number of G proteins activated. To test this model C6 μ cells were treated with the irreversible μ-antagonist β-funaltrexamine (10 nM) prior to permeabilization. This reduced the number of μ-opioid receptors determined with [3H]diprenorphine to 23 ± 3% of control with no change in affinity. A commensurate reduction (to 29 ± 10% of control) in the level of [35S]GTPγS binding stimulated by DAMGO was observed, but thet1/2 for [35S]GTPγS binding remained unchanged. Thus, random encounters of receptor and G protein failed to occur in this permeabilized cell preparation. A model that assumes an organized association of G proteins with receptors better describes the activation of G proteins by opioid μ-receptors. The American Society for Pharmacology and Experimental Therapeutics